Navigation Links
Biomarkers Market Worth $25.79 Billion by 2016 – New Report by MarketsandMarkets

(PRWEB) September 21, 2013

The report “Biomarkers Market (Discovery Technologies, Applications & Indications) – Global Trends, Opportunities & Forecasts (2011 – 2020)”, as the name suggests, analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World.

Browse market data tables and in-depth TOC on the “Biomarkers Market:”

Early buyers will receive 10% customization on this report.

Biomarkers are defined by Biomarkers Consortium as “Characteristics that are objectively measured and evaluated as indicators of normal biological processes, pathogenic processes, or pharmacologic responses to therapeutic intervention.” Biomarkers are an active area of medical research and are showing a growth due to the potential they hold for targeted therapy or personalized medicine.

Biomarker caters the need of biopharmaceutical companies in drug discovery and development process and companion diagnostics. The global Biomarker market is estimated to grow at a CAGR of 14.40% during the study period (2011-2016).

In this report, the global biomarker market is studied by the biomarker discovery technologies, its application in drug discovery & development process, personalized medicine and molecular diagnostics across major indications such as oncology, cardiology, neurology and other indications which include arthritis, renal failure, HIV, tuberculosis, and diabetes. North America is leading the global CTMS market with around 50% share in 2011.

The North American market as a whole are a growing demand for higher capacities of the disease, diagnosis and treatment of aging, a higher rate of technology adoption and requirements of a growing biomarkers market in drug discovery and development. The U.S. is the largest market, and shows a remarkable growth opportunity. Europe is the second largest market while Asia-Pacific is the fastest growing region.

Browse Related Reports
Global Wireless Sensors Market for Environmental and Agricultural Monitoring (2011-2016)

Global GPS Market: Products (Marine, Aviation, Automotive, Outdoor/fitness & GPS Enabled Smart Phones), Applications (Navigation, Machine Control, & Logistics Tracking) & Geography (2011 - 2016)

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-6006-441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog @
Connect with us on LinkedIn @

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Researchers to identify genetic biomarkers for aggressive breast cancer
2. Researchers develop specific tests to identify cancer biomarkers in dermatomyositis
3. Global Oncology Biomarkers Market to Reach US $9.5 Billion by 2014 at a CAGR of 18.1% - New Report by MarketsandMarkets
4. New concussion data: 2 biomarkers better than 1
5. Researchers narrow the search for biomarkers of drug resistance in head and neck cancer patients
6. Biomarkers discovered for inflammatory bowel disease
7. Leading researchers report on the elusive search for biomarkers in Huntingtons disease
8. Trio of biomarkers may help identify kidney cancer in early stages
9. Biomarkers may help predict progression of Barretts esophagus to esophageal adenocarcinoma
10. Mayo Clinic-led study identifies biomarkers for early risk assessment of acute kidney injury
11. NIH launches collaborative effort to find biomarkers for Parkinsons
Post Your Comments:
(Date:11/28/2015)... ... , ... Safe storage for contraceptive devices may not always be easy to ... and the other from Bradley Beach, New Jersey, there is an easy solution to ... to replace NuvaRings more often than necessary. As such, it affords peace of mind ...
(Date:11/27/2015)... ... November 28, 2015 , ... There is only one major question facing ... last year? , This question has not been an easy question to answer. Especially ... age and the younger workforce don’t share the same discipline around working long hours. ...
(Date:11/27/2015)... ... 27, 2015 , ... The rapid speed at which Americans ... more care is needed, especially with Alzheimer’s, dementia and other cognitive conditions becoming ... The forgotten part of this equation: 80 percent of medical care occurs in ...
(Date:11/27/2015)... ... 27, 2015 , ... Lizzie’s Lice Pickers just announced a special promotion that ... of their purchase of lice treatment product. In addition, customers will receive a complimentary ... spokesperson. “Finding lice is a sure way to ruin the holidays, so we encourage ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... of progress through sharing, the 2016 Building Better Radiology Marketing Programs ... will begin on Sunday, March 6, 2016, at Caesars Palace in Las Vegas ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ... the "2016 Future Horizons and Growth Strategies ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> --> This ... the Italian therapeutic drug monitoring market, including emerging ...
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: AMGN ... Application (BLA) with the United States ... 501, a biosimilar candidate to Humira ® (adalimumab). ... application submitted to the FDA and represents Amgen,s first ... Sean E. Harper , M.D., executive vice president of ...
(Date:11/25/2015)... Nov. 25, 2015  ARKRAY USA ... to provide evidence demonstrating the accuracy of its blood ... on Insulin Resistance, Diabetes and Cardiovascular Disease in ... the Company,s GLUCOCARD ® 01 meter and the ... requirements. The ability to accurately measure glucose levels in ...
Breaking Medicine Technology: